Ministry of Industry, ‘BIO USA’ supports Korean bio-companies to advance to the global market |

news/photo/202306/35848_41661_100.jpg?resize=600%2C338&ssl=1" alt="산업통상자원부 전경." width="600" height="338" layout="responsive" class="amp_f_img" data-recalc-dims="1"/>
A look at the Ministry of Trade, Industry and Energy.

The Ministry of Trade, Industry and Energy and the KOTRA Bio Association will support the entry of domestic bio companies into the global market at the ‘International Bio Convention 2023 (BIO USA) 2023’ held in Boston, USA on the 5th to the 8th .

‘BIO USA’ is the world’s largest exhibition/conference in the bio field, which is celebrating its 31st anniversary this year. This year, around 9,100 bio companies from 85 countries, including US pharmaceutical companies Merck & Company (MSD) and Pfizer, will participate to showcase innovative technologies and excellent products.

In Korea, 544 companies and organizations, more than twice as many as last year, are expected to record the highest participation ever.

The Ministry of Trade, Industry and Energy, together with KOTRA and the Korea Bio Association, has been operating the Korea Pavilion, a unique exhibition and promotion hall for domestic bio companies, at BIO USA since 2000. This year, 20 companies will domestic bio, including Binex and Ubiologics, participating in the Korean Pavilion to promote their products and offer one-on-one business consultations.

Major domestic bio companies such as Samsung Biologics, Celltrion, and Lotte Bilogics also operate independent publicity booths for their publicity and order-winning activities.

Meanwhile, the Ministry of Trade, Industry and Energy will hold a ‘Korea-US Bio Roundtable’ on the 7th in cooperation with the Korea-US Bio Association. This is a subsequent measure to the memorandum of understanding (MOU) signed on the occasion of the president’s state visit to the United States in April this year.

At the round table, large domestic companies such as Samsung Bioepis, Celltrion, and SK Biopharmaceuticals attended and discussed, as well as heads of bio-companies from both countries, and large pharmaceuticals such as MSD and BMS (Bristol-Myers Squibb) from the US. ways to co-operate to establish a bioindustry supply chain plan to be discussed.

Reporter Lee Han-soo


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.